MDxHealth SA (MDXH)
Last updated: 2026-10-24 02:47:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
MDxHealth SA (MDXH) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $0.18, with a market capitalization of $20.50M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.17 to $5.33. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$20.50M | |
$0.19 | |
$131.70 | |
$0.17 | |
$0.18 | |
641.77K | |
6.22M | |
-- | |
$5.33 | |
$0.17 | |
-- | |
-- |
MDxHealth SA (MDXH) Latest Closing Stock Price
MDxHealth SA (MDXH) last closed at $0.18 as of 2026-10-24 00:00:00, unchanged from the previous close of $0.18.
During the latest regular trading session, MDXH traded between $0.17 and $131.70, with a volume of 641.77K shares. The closing price was near the lower end and near the lower end of its 52-week range.
MDxHealth SA (MDXH) 7-Day Stock Price Change
Over the past seven days, MDxHealth SA (MDXH) moved from $0.63 to $0.18, representing a decline of 70.87% ($0.45).
The stock traded between $0.17 and $0.68 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 4.40 million shares, up versus the previous seven-day period, indicating higher trading activity.
MDXH 52-Week Price Position
Position in Range: 0.3%
MDXH is currently trading at $0.18, placing it 0.3% of the way from its 52-week low of $0.17 to its 52-week high of $5.33. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is MDxHealth SA (MDXH)?
MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.
MDxHealth SA Information
| Employees | 364 |
| Exchange | NASDAQ |
| Company Website |
How to Buy MDxHealth SA (MDXH) Stock on MEXC
Eligible investors can buy real shares of MDxHealth SA (MDXH) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is MDxHealth SA (MDXH) stock price today?
2.Is MDXH stock going up or down today?
3.What is MDXH pre-market price?
4.What is MDXH after-hours price?
5.Is MDXH stock trading now?
6.Where does MDXH sit relative to its 52-week high and low?
7.What sector is MDxHealth SA in?
8.What is MDxHealth SA's market capitalization and where is it listed?
9.How is MDXH valued in terms of P/E ratio and EPS?
10.Does MDxHealth SA pay a dividend?
Explore More US Stocks
Search Stocks
MDXH Stock Calculator
Estimate the value between MDXH shares and USD.
MDXH Shares to USD
1.00 MDXH shares = 0.184 USD
Calculations are estimates based on the latest available price and are for reference only.


